In less than five years, Synceres Biosciences has emerged as a standout player in the synthetic biology industry, valued at over $137.95 million. The company's transformation from a humble startup to a high-tech powerhouse with substantial funding and a rapidly growing workforce underscores its remarkable journey.
The success of Synceres Biosciences is intricately linked to the innovation ecosystem of Guangming Science City. Co-founder Luo Xiaozhou credits the Industrial Innovation Center for Engineering Biology for providing a platform that bridges research and commercialization, enabling startups to thrive and scale up their operations effectively.
Situated in the heart of Guangming Science City, Synceres Biosciences is part of a vibrant community of synthetic biology enterprises, including notable names like Bontac Bio-engineering and Cytorola Biomedical. This clustering of innovative companies fosters collaboration, accelerates breakthroughs, and drives industrial applications in the field.
Researchers at the Shenzhen Institute of Synthetic Biology, iSynBio, collaborate closely with companies like Synceres Biosciences to push the boundaries of synthetic biology. By focusing on original innovations and core technologies, these partnerships drive advancements in key areas of the industry, fostering a culture of continuous innovation
Synceres Biosciences' collaboration with SIAT and the Innovation Center extends beyond research to include joint labs and shared resources. This synergy between research institutions and startups facilitates the seamless integration of innovation, industry, capital, and talent chains, propelling the growth and success of companies in the Science City.
